GenBioPro

Last updated
GenBioPro
Industry Pharmaceutical
HeadquartersUnited States
Area served
United States
Products mifepristone
Website https://genbiopro.com/

GenBioPro is a United States pharmaceutical company which makes and distributes a generic version of the medication abortion drug mifepristone.

Contents

History

In 1999 GenBioPro obtained Food and Drug Administration (FDA) authorization to sell a generic version of mifepristone (before that, Danco Laboratories was the only company that distributed it in the United States).

In 2000, GenBioPro's generic version of mifepristone was approved for medication abortion, as part of a two-drug regimen in combination with misoprostol.

In 2023, GenBioPro sued the FDA to obtain a legal judgement confirming that mifepristone could continue to be sold, in spite of anti-abortion laws passed in some states. [1] [2]

See also

References

  1. "Generic abortion pill manufacturer sues FDA in effort to preserve access" Sarah McCammon April 19, 2023 NPR https://www.npr.org/2023/04/19/1170806176/abortion-pill-mifepristone-supreme-court-fda-generic-genbiopro
  2. Belluck, Pam (2023-04-19). "Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market". The New York Times. ISSN   0362-4331 . Retrieved 2025-03-06.